Publication | Closed Access

Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS®), with commercial lipid-based formulations

Lipid PreparationNanomedicineCommercial Lipid-based FormulationsPharmaceutical ScienceEngineeringMedicineAmphotericin BPharmacotherapyBiomedical EngineeringNovel Low-dose FormulationDrug Delivery SystemPharmacologyPharmaceutical Research